Logo image of PNOR.OL

PETRONOR E&P ASA (PNOR.OL) Stock Fundamental Analysis

Europe - OSL:PNOR - NO0012942525 - Common Stock

10.17 NOK
+0.02 (+0.2%)
Last: 9/19/2025, 2:03:57 PM
Fundamental Rating

7

Taking everything into account, PNOR scores 7 out of 10 in our fundamental rating. PNOR was compared to 65 industry peers in the Oil, Gas & Consumable Fuels industry. PNOR scores excellent points on both the profitability and health parts. This is a solid base for a good stock. PNOR is valued quite cheap, but it does not seem to be growing. This makes PNOR very considerable for value investing!


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

PNOR had positive earnings in the past year.
PNOR had a positive operating cash flow in the past year.
PNOR had positive earnings in each of the past 5 years.
Of the past 5 years PNOR 4 years had a positive operating cash flow.
PNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFPNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M

1.2 Ratios

The Return On Assets of PNOR (8.81%) is better than 78.46% of its industry peers.
PNOR's Return On Equity of 13.53% is fine compared to the rest of the industry. PNOR outperforms 63.08% of its industry peers.
PNOR has a Return On Invested Capital of 17.64%. This is amongst the best in the industry. PNOR outperforms 92.31% of its industry peers.
The Average Return On Invested Capital over the past 3 years for PNOR is significantly above the industry average of 9.96%.
The 3 year average ROIC (25.97%) for PNOR is well above the current ROIC(17.64%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 8.81%
ROE 13.53%
ROIC 17.64%
ROA(3y)18.05%
ROA(5y)13.4%
ROE(3y)28.54%
ROE(5y)27.26%
ROIC(3y)25.97%
ROIC(5y)29.21%
PNOR.OL Yearly ROA, ROE, ROICPNOR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -100 -200

1.3 Margins

PNOR has a better Profit Margin (13.40%) than 67.69% of its industry peers.
In the last couple of years the Profit Margin of PNOR has grown nicely.
With an excellent Operating Margin value of 41.84%, PNOR belongs to the best of the industry, outperforming 92.31% of the companies in the same industry.
In the last couple of years the Operating Margin of PNOR has remained more or less at the same level.
Looking at the Gross Margin, with a value of 49.30%, PNOR is in line with its industry, outperforming 58.46% of the companies in the same industry.
PNOR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 41.84%
PM (TTM) 13.4%
GM 49.3%
OM growth 3Y-9.51%
OM growth 5Y-1.13%
PM growth 3Y12.45%
PM growth 5YN/A
GM growth 3Y-10.4%
GM growth 5Y-5.31%
PNOR.OL Yearly Profit, Operating, Gross MarginsPNOR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M -60M -80M

10

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), PNOR is creating value.
Compared to 1 year ago, PNOR has about the same amount of shares outstanding.
The number of shares outstanding for PNOR has been reduced compared to 5 years ago.
PNOR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
PNOR.OL Yearly Shares OutstandingPNOR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
PNOR.OL Yearly Total Debt VS Total AssetsPNOR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 3.61 indicates that PNOR is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.61, PNOR belongs to the top of the industry, outperforming 81.54% of the companies in the same industry.
PNOR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 3.61
ROIC/WACC2.07
WACC8.52%
PNOR.OL Yearly LT Debt VS Equity VS FCFPNOR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

A Current Ratio of 3.97 indicates that PNOR has no problem at all paying its short term obligations.
PNOR has a better Current ratio (3.97) than 93.85% of its industry peers.
PNOR has a Quick Ratio of 3.53. This indicates that PNOR is financially healthy and has no problem in meeting its short term obligations.
PNOR's Quick ratio of 3.53 is amongst the best of the industry. PNOR outperforms 92.31% of its industry peers.
Industry RankSector Rank
Current Ratio 3.97
Quick Ratio 3.53
PNOR.OL Yearly Current Assets VS Current LiabilitesPNOR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

3

3. Growth

3.1 Past

PNOR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -81.18%.
Measured over the past years, PNOR shows a very strong growth in Earnings Per Share. The EPS has been growing by 38.60% on average per year.
PNOR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -61.56%.
The Revenue has been growing by 14.76% on average over the past years. This is quite good.
EPS 1Y (TTM)-81.18%
EPS 3Y38.6%
EPS 5YN/A
EPS Q2Q%-60.23%
Revenue 1Y (TTM)-61.56%
Revenue growth 3Y24.31%
Revenue growth 5Y14.76%
Sales Q2Q%-79.4%

3.2 Future

PNOR is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -41.61% yearly.
The Revenue is expected to decrease by -20.47% on average over the next years. This is quite bad
EPS Next Y-25%
EPS Next 2Y-41.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-15.06%
Revenue Next 2Y-20.47%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
PNOR.OL Yearly Revenue VS EstimatesPNOR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 50M 100M 150M 200M
PNOR.OL Yearly EPS VS EstimatesPNOR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4

7

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 8.84, which indicates a very decent valuation of PNOR.
78.46% of the companies in the same industry are more expensive than PNOR, based on the Price/Earnings ratio.
PNOR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.41.
The Price/Forward Earnings ratio is 6.78, which indicates a rather cheap valuation of PNOR.
Based on the Price/Forward Earnings ratio, PNOR is valued cheaper than 86.15% of the companies in the same industry.
PNOR is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.84
Fwd PE 6.78
PNOR.OL Price Earnings VS Forward Price EarningsPNOR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of PNOR indicates a rather cheap valuation: PNOR is cheaper than 100.00% of the companies listed in the same industry.
93.85% of the companies in the same industry are more expensive than PNOR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 3.13
EV/EBITDA 0.43
PNOR.OL Per share dataPNOR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

PNOR has a very decent profitability rating, which may justify a higher PE ratio.
PNOR's earnings are expected to decrease with -41.61% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-41.61%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

PNOR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

PETRONOR E&P ASA

OSL:PNOR (9/19/2025, 2:03:57 PM)

10.17

+0.02 (+0.2%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-20 2025-08-20
Earnings (Next)11-20 2025-11-20
Inst Owners0.9%
Inst Owner ChangeN/A
Ins Owners2.25%
Ins Owner ChangeN/A
Market Cap1.45B
Analysts82.86
Price Target13.26 (30.38%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 8.84
Fwd PE 6.78
P/S 0.85
P/FCF 3.13
P/OCF 2.43
P/B 0.86
P/tB 0.9
EV/EBITDA 0.43
EPS(TTM)1.15
EY11.31%
EPS(NY)1.5
Fwd EY14.75%
FCF(TTM)3.25
FCFY31.99%
OCF(TTM)4.18
OCFY41.14%
SpS11.99
BVpS11.87
TBVpS11.31
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 8.81%
ROE 13.53%
ROCE 31.29%
ROIC 17.64%
ROICexc 32.75%
ROICexgc 35.02%
OM 41.84%
PM (TTM) 13.4%
GM 49.3%
FCFM 27.12%
ROA(3y)18.05%
ROA(5y)13.4%
ROE(3y)28.54%
ROE(5y)27.26%
ROIC(3y)25.97%
ROIC(5y)29.21%
ROICexc(3y)33.15%
ROICexc(5y)39.25%
ROICexgc(3y)39.5%
ROICexgc(5y)46.11%
ROCE(3y)47.13%
ROCE(5y)55.34%
ROICexcg growth 3Y-21.92%
ROICexcg growth 5Y-46.42%
ROICexc growth 3Y-20.01%
ROICexc growth 5Y-37.94%
OM growth 3Y-9.51%
OM growth 5Y-1.13%
PM growth 3Y12.45%
PM growth 5YN/A
GM growth 3Y-10.4%
GM growth 5Y-5.31%
F-Score5
Asset Turnover0.66
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 67.35%
Cap/Sales 7.76%
Interest Coverage 224.87
Cash Conversion 65.37%
Profit Quality 202.47%
Current Ratio 3.97
Quick Ratio 3.53
Altman-Z 3.61
F-Score5
WACC8.52%
ROIC/WACC2.07
Cap/Depr(3y)235.93%
Cap/Depr(5y)264.03%
Cap/Sales(3y)18.03%
Cap/Sales(5y)16.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-81.18%
EPS 3Y38.6%
EPS 5YN/A
EPS Q2Q%-60.23%
EPS Next Y-25%
EPS Next 2Y-41.61%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-61.56%
Revenue growth 3Y24.31%
Revenue growth 5Y14.76%
Sales Q2Q%-79.4%
Revenue Next Year-15.06%
Revenue Next 2Y-20.47%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-63.29%
EBIT growth 3Y12.49%
EBIT growth 5Y13.46%
EBIT Next Year-7.92%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y385.71%
FCF growth 3YN/A
FCF growth 5Y9.26%
OCF growth 1Y22.93%
OCF growth 3Y50.47%
OCF growth 5Y7.36%